LIGAND PHARMACEUTICALS INCORPORATED
Shares Outstanding
| Period | Shares Outstanding |
|---|---|
| Feb 2017 | 20.9M |
| Mar 2017 | 24.8M |
| May 2017 | 21.0M |
| Jun 2017 | 24.4M |
| Jul 2017 | 21.1M |
| Sep 2017 | 24.1M |
| Oct 2017 | 21.1M |
| Dec 2017 | 21.1M |
| Feb 2018 | 21.2M |
| Mar 2018 | 24.8M |
| Apr 2018 | 21.3M |
| Jun 2018 | 24.4M |
| Aug 2018 | 21.1M |
| Sep 2018 | 24.1M |
| Nov 2018 | 21.3M |
| Dec 2018 | 21.1M |
| Feb 2019 | 20.4M |
| Mar 2019 | 21.3M |
| May 2019 | 19.6M |
| Jun 2019 | 19.6M |
| Aug 2019 | 19.0M |
| Sep 2019 | 18.8M |
| Nov 2019 | 17.6M |
| Dec 2019 | 17.2M |
| Feb 2020 | 16.5M |
| Mar 2020 | 16.5M |
| May 2020 | 16.0M |
| Jun 2020 | 16.7M |
| Aug 2020 | 16.1M |
| Sep 2020 | 16.1M |
| Nov 2020 | 16.1M |
| Dec 2020 | 16.7M |
| Feb 2021 | 16.6M |
| Mar 2021 | 17.2M |
| May 2021 | 16.7M |
| Jun 2021 | 17.2M |
| Jul 2021 | 16.7M |
| Sep 2021 | 17.1M |
| Nov 2021 | 16.7M |
| Dec 2021 | 16.7M |
| Feb 2022 | 16.9M |
| Mar 2022 | 16.8M |
| May 2022 | 16.9M |
| Jun 2022 | 17.1M |
| Aug 2022 | 16.9M |
| Sep 2022 | 17.1M |
| Nov 2022 | 16.9M |
| Dec 2022 | 16.9M |
| Feb 2023 | 17.1M |
| Mar 2023 | 18.0M |
| May 2023 | 17.3M |
| Jun 2023 | 17.7M |
| Aug 2023 | 17.4M |
| Sep 2023 | 17.4M |
| Nov 2023 | 17.4M |
| Dec 2023 | 17.6M |
| Feb 2024 | 17.7M |
| Mar 2024 | 18.1M |
| May 2024 | 18.0M |
| Jun 2024 | 18.0M |
| Aug 2024 | 18.3M |
| Sep 2024 | 18.4M |
| Nov 2024 | 18.9M |
| Dec 2024 | 19.1M |
| Feb 2025 | 19.3M |
| Mar 2025 | 19.2M |
| May 2025 | 19.3M |
| Jun 2025 | 19.9M |
| Aug 2025 | 19.6M |
| Sep 2025 | 20.6M |
| Nov 2025 | 19.7M |
| Dec 2025 | 19.8M |
| Feb 2026 | 19.9M |
| Mar 2026 | 19.9M |
| May 2026 | 20.0M |
| Jun 2026 | 21.8M |
| Aug 2026 | 19.9M |